StockData
CytoDyn Inc. logo

CytoDyn Inc. (CYDY) stock

CYDYOTCPharmaceutical PreparationsFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 14, 2026Score 4/30
$0.25+0.02 (+9.53%)

Close on Oct 19, 2026Market cap $345.56MP/E –Yield –

CytoDyn pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

CytoDyn's pe ratio was 86.7× on Sep 30, 2025.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Sep 30, 202586.7×–

More CytoDyn figures

See a number that looks wrong?